{"url_path":"/sec/trvi/8-k/2026-06-04/item-5-03","section_key":"item-5-03","section_title":"Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-04","source_url":"https://www.sec.gov/Archives/edgar/data/1563880/0001193125-26-257365-index.html","accession_number":"0001193125-26-257365","cik":"0001563880","ticker":"TRVI","issuer_name":"Trevi Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1563880/0001193125-26-257365-index.html","primary_entity_key":"0001563880","primary_entity_name":"Trevi Therapeutics, Inc."},"word_count":138,"has_tables":true,"body_markdown":"Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\n\n \n\nAt the Annual Meeting, the Company’s stockholders approved an amendment (the “Amendment”) to the Company’s restated certificate of incorporation (“Certificate of Incorporation”) to increase the number of authorized shares of the Company’s common stock from 200,000,0000 shares to 400,000,000 shares.\n\n \n\nThe Amendment became effective upon the Company’s filing of a Certificate of Amendment to the Restated Certificate of Incorporation with the Secretary of State of the State of Delaware on June 3, 2026 (the “Certificate of Amendment”).\n\n \n\nThe foregoing description of the terms of the Amendment does not purport to be complete and is qualified in its entirety by reference to the full text of the Certificate of Amendment, a copy of which is attached as Exhibit 3.1 hereto and is incorporated by reference herein."}